Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019

Emergent BioSolutions (EBS) Tops Q3 EPS by 31c

November 6, 2019 4:53 PM EST

Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $1.21, $0.31 better than the analyst estimate of $0.90. Revenue for the quarter came in at $311.8 million versus the consensus estimate of $289.27 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More